Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.125 1 day ( 0 % )
Last Price $19.05 -0.626 %
High/ Low $19.03 - $19.52 -1.05%
Chg 7 Days -3.64 % $19.77 $19.05
Chg 30 Days 6.66 % $17.86 $19.05
Chg 12 mos 38.34 % $13.77 $19.05
Trend - 3 mos -7.04 % Width: 23.15 %
Trend - 12 mos 25.57 % Width: 35.34 %
Pred. range - 3 mos $15.11 - $18.61 -20.68 % - -2.32 %
Pred. range - 12 mos $21.18 - $28.67 11.20 % - 50.50 %
Short MA avg 3 mos Sell May 16, 2024 - 7 days
Long MA avg 3 mos Buy Apr 29, 2024 - 20 days
Short/Long MA avg 3 mos Buy May 02, 2024 - 17 days
Short MA avg 12 mos Sell May 21, 2024 - 4 days
Long MA avg 12 mos Sell May 22, 2024 - 3 days
Short/Long MA avg 12 mos Buy May 17, 2024 - 6 days
Pivot Short Sell Apr 18, 2024 - 27 days
Bollinger Buy May 06, 2024 - 15 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Kiniksa Pharmaceuticals Ltd. Class A

Kiniksa Pharmaceuticals Ltd. Class A Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclo... KNSA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT